Publications: Larcher, Leon

2021

Du, R., Wang, X., Ma, L., Larcher, L.M., Tang, H., Zhou, H., Chen, C. and Wang, T. (2021) Adverse reactions of targeted therapy in cancer patients: A retrospective study of hospital medical data in China. BMC Cancer, 21 (1). Art. 206.

2020

Du, R., Wang, P., Ma, L., Larcher, L.M., Wang, T. and Chen, C. (2020) Health-related quality of life and associated factors in patients with myocardial infarction after returning to work: A cross-sectional study. Health and Quality of Life Outcomes, 18 (1). Art. 180.

Yang, D., Zhang, W., Zhang, H., Zhang, F., Chen, L., Ma, L., Larcher, L.M., Chen, S., Liu, N., Zhao, Q., Tran, P.H.L., Chen, C., Veedu, R.N. and Wang, T. (2020) Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics, 10 (8). pp. 3684-3707.

Balachandran, A.A., Larcher, L.M., Chen, S. and Veedu, R.N. (2020) Therapeutically significant MicroRNAs in primary and metastatic brain malignancies. Cancers, 12 (9). Article 2534.

2019

Larcher, L.M., Wang, T. and Veedu, R.N. (2019) Development of novel antimiRzymes for targeted inhibition of miR-21 expression in solid cancer cells. Molecules, 24 (13). p. 2489.

2018

Larcher, Leon Maria (2018) Development of novel oligonucleotide therapeutic molecules targeting microRNAs for tackling brain cancers. Honours thesis, Murdoch University.

Wang, T., Larcher, L., Ma, L. and Veedu, R. (2018) Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides. Molecules, 23 (10). p. 2564.

Wang, T., Chen, C., Larcher, L., Barrero, R.A. and Veedu, R.N. (2018) Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development. Biotechnology Advances, 37 (1). pp. 28-50.